Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FQJAQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,093
Award facts
- Contract value 100% obligated
- $14,093.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Zepbound 10 mg/0.5 ml pens in 0.5 ml quantities, valued at $14,093.41. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a competitively awarded contract with no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor contract through December 2026 that supports comprehensive pharmaceutical and medical supply needs across the Department of Defense and affiliated federal healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of delivery orders from the DLA. The company supplies a broad range of pharmaceutical products spanning multiple therapeutic domains, from specialty medications to generic drugs, vaccines, and medical devices. Zepbound, a tirzepatide-based medication used for weight management, represents one of the specialized pharmaceuticals within AmerisourceBergen's federal supply network. The award reflects the company's continued capability to fulfill federal procurement requirements for military and veteran healthcare systems through open competition on the DLA's comprehensive global pharmaceutical support vehicle.
Quick answers
Who was awarded contract SPE2DB25FQJAQ?
SPE2DB25FQJAQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FQJAQ worth?
The government has obligated $14,093 on SPE2DB25FQJAQ.
Is contract SPE2DB25FQJAQ an order under another contract?
Yes. SPE2DB25FQJAQ is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJAQ competed?
The extent of competition for SPE2DB25FQJAQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award